{
  "title": "Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications.",
  "pmid": "39592577",
  "doi": null,
  "affiliations": [
    "Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Brussels, Belgium.",
    "Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Brussels, Belgium.",
    "Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Brussels, Belgium.",
    "Department of Pathology, University Hospital Center of Liège, Liège, Belgium.",
    "Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Brussels, Belgium.",
    "Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Brussels, Belgium.",
    "Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden.",
    "Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Brussels, Belgium.",
    "Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Brussels, Belgium.",
    "Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Brussels, Belgium.",
    "Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Brussels, Belgium.",
    "Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Brussels, Belgium.",
    "Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Brussels, Belgium.",
    "Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Brussels, Belgium.",
    "Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Brussels, Belgium.",
    "Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Brussels, Belgium.",
    "Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden.",
    "Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden.",
    "Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden.",
    "Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden.",
    "Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden.",
    "Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden.",
    "Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden.",
    "Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden.",
    "Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Brussels, Belgium.",
    "Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Brussels, Belgium. christos.sotiriou@hubruxelles.be.",
    "Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Brussels, Belgium. christos.sotiriou@hubruxelles.be."
  ]
}